Clinical trial
Australian Prospective Clinical Study of the Apnex Medical Hypoglossal Nerve Stimulation (HGNS) System to Treat Obstructive Sleep Apnea
NCT01186926 is registered in ClinicalTrials.gov with Apnex Medical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Australian Prospective Clinical Study of the Apnex Medical Hypoglossal Nerve Stimulation (HGNS) System to Treat Obstructive Sleep Apnea
- Lead sponsor
- Apnex Medical, Inc.
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- March 31, 2009
- Completion date
- May 31, 2013
- Enrollment
- 40 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
obstructive sleep apnea